Multiparametric prostate MRI improves the diagnosis of a clinically significant prostate cancer in PSA screening; but what is the benefit of additional risk calculators? https://www.nature.com/articles/s41391-025-01058-4

A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1 https://www.nature.com/articles/s41467-025-66558-2

Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer https://www.nature.com/articles/s41698-025-01179-y

Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis https://www.nature.com/articles/s41391-025-01057-5

NSD2 targeting reverses plasticity and drug resistance in prostate cancer https://www.nature.com/articles/s41586-025-09727-z